Home » Newsletters » BioWorld Science

BioWorld Science

May 13, 2014

View Archived Issues

Brazilian researchers characterize novel small-molecule inhibitors of inflammatory cytokines

Lanreotide autogel improves symptoms of diarrhea and QoL

Novel topical formulation of alpha-LACE for the treatment of presbyopia

Cortistatin derivative shows potential in experimental CNV

Alcobra to initiate phase IIb study of metadoxine in Fragile X syndrome

Pharmacokinetic data presented for novel cyclic boronic acid beta-lactamase inhibitor

Nuvilex and University of Northern Colorado to research cannabinoids for cancer

U.S. investigators patent novel steroids acting on GABA(A) receptors

AMAGINE-1 study of brodalumab in moderate to severe plaque psoriasis meets endpoints

ReNeuron presents promising phase I data for the CTX0E03 cell therapy in stroke patients

Tripeptide KdPT evaluated in proof-of-concept ulcerative colitis trial

Takeda reviews highlights of fourth quarter of fiscal 2013

AC Immune and Piramal Imaging form agreement for Tau protein diagnostics

Novavax reports follow-up data from phase I RSV F-protein vaccine trial

Abeona Therapeutics' therapies obtain orphan drug designation for Sanfilippo syndrome

Lilly reports positive phase III results for insulin peglispro

Results from phase IIb studies of MedImmune's mavrilimumab and sifalimumab

Idenix Pharmaceuticals reports discovery of dinucleotide compounds for HCV

Janssen Pharmaceutica discloses new ROR-gamma modulators

Novel C9orf72 mRNA expression modulators disclosed by Isis Pharmaceuticals

Tesaro reports positive data from phase III trial of rolapitant

Santhera's phase III study of idebenone for DMD meets primary endpoint

GSK's darapladib misses primary endpoint in acute coronary syndrome trial

Shire acquires Lumena Pharmaceuticals and two new therapeutic compounds

AstraZeneca announces phase III results for saxagliptin/dapagliflozin combination

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.